Clinical Trials Browser

Terminated × nirogacestat × Plasma cell × Clear all

NCT04171843 2023-09-21

A Dose-escalation Study to Evaluate the Safety and Clinical Activity of PBCAR269A, With or Without Nirogacestat, in Study Participants With Relapsed/Refractory Multiple Myeloma

Phase 1 Terminated

Multiple Myeloma